PH22236A - Rat hypothalamic grf, pharmaceutical compositions containing the same and method of use thereof - Google Patents
Rat hypothalamic grf, pharmaceutical compositions containing the same and method of use thereofInfo
- Publication number
- PH22236A PH22236A PH30570A PH30570A PH22236A PH 22236 A PH22236 A PH 22236A PH 30570 A PH30570 A PH 30570A PH 30570 A PH30570 A PH 30570A PH 22236 A PH22236 A PH 22236A
- Authority
- PH
- Philippines
- Prior art keywords
- same
- pharmaceutical compositions
- compositions containing
- rat hypothalamic
- grf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/488,748 US4595676A (en) | 1983-04-26 | 1983-04-26 | Rat hypothalamic GRF |
Publications (1)
Publication Number | Publication Date |
---|---|
PH22236A true PH22236A (en) | 1988-07-01 |
Family
ID=23940961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH30570A PH22236A (en) | 1983-04-26 | 1984-04-17 | Rat hypothalamic grf, pharmaceutical compositions containing the same and method of use thereof |
Country Status (7)
Country | Link |
---|---|
US (1) | US4595676A (cs) |
CA (1) | CA1247601A (cs) |
CS (1) | CS272758B2 (cs) |
HU (1) | HU199508B (cs) |
NZ (1) | NZ207658A (cs) |
PH (1) | PH22236A (cs) |
SU (1) | SU1477248A3 (cs) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732972A (en) * | 1983-03-07 | 1988-03-22 | Hoffmann-La Roche Inc. | Polypeptides having growth hormone releasing activity |
US4689318A (en) * | 1985-08-29 | 1987-08-25 | The Salk Institute For Biological Studies | GRF analogs |
US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
US5002931A (en) * | 1987-05-22 | 1991-03-26 | The Salk Institute For Biological Studies | GRF analogs VII |
US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
US4801456A (en) * | 1987-07-09 | 1989-01-31 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
USRE33699E (en) * | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
US4880777A (en) * | 1987-09-01 | 1989-11-14 | Eastman Kodak Company | Synthetic peptides having growth hormone releasing activity |
EP0400051B1 (en) * | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
US5043322A (en) * | 1988-07-22 | 1991-08-27 | The Salk Institute For Biological Studies | Cyclic GRF analogs |
US5756458A (en) * | 1989-06-16 | 1998-05-26 | Pharmacia & Upjohn Company | Stabilized potent GRF analogs |
WO1992000095A1 (en) * | 1990-06-29 | 1992-01-09 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
DK0490249T3 (da) * | 1990-12-10 | 1995-05-29 | Hoffmann La Roche | Fremgangsmåde til enzymatisk fremstilling af GRF(1-44)-NH2 |
WO1992018531A1 (en) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Growth hormone releasing factor analogs |
US5246920A (en) * | 1992-06-15 | 1993-09-21 | University Of South Florida | Treatment of hyperprolactinemia |
US5811074A (en) * | 1992-06-29 | 1998-09-22 | University Of South Florida | Method of diagnosing pituitary dependent growth hormone deficiency |
AU2002233082B2 (en) * | 2001-02-02 | 2005-11-10 | Conjuchem Biotechnologies Inc. | Long lasting growth hormone releasing factor derivatives |
RU2005111253A (ru) * | 2002-09-18 | 2005-11-20 | Сантр Оспиталье Де Л` Юниверсите Де Монреаль (Схюм) (Ca) | Аналоги ghrh |
WO2009009727A2 (en) * | 2007-07-12 | 2009-01-15 | Akela Pharma Srl | Ghrh analogs and therapeutic uses thereof |
-
1983
- 1983-04-26 US US06/488,748 patent/US4595676A/en not_active Expired - Lifetime
-
1984
- 1984-01-10 CS CS20084A patent/CS272758B2/cs unknown
- 1984-01-12 HU HU8488A patent/HU199508B/hu unknown
- 1984-01-12 SU SU843692330A patent/SU1477248A3/ru active
- 1984-03-22 CA CA000450244A patent/CA1247601A/en not_active Expired
- 1984-03-27 NZ NZ207658A patent/NZ207658A/xx unknown
- 1984-04-17 PH PH30570A patent/PH22236A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS272758B2 (en) | 1991-02-12 |
HU199508B (en) | 1990-02-28 |
US4595676A (en) | 1986-06-17 |
CA1247601A (en) | 1988-12-28 |
CS20084A2 (en) | 1990-06-13 |
SU1477248A3 (ru) | 1989-04-30 |
NZ207658A (en) | 1988-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL76591A0 (en) | Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof | |
DE3466476D1 (en) | External pharmaceutical composition | |
ZA859756B (en) | Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same | |
PH21506A (en) | New pharmaceutical composition based on valporic acid | |
PH22236A (en) | Rat hypothalamic grf, pharmaceutical compositions containing the same and method of use thereof | |
IL72085A0 (en) | 13alpha-alkylylgonanes,processes for their preparation and pharmaceutical compositions containing the same | |
IL72566A (en) | Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same | |
EP0157346A3 (en) | Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same | |
PT78570A (en) | Process for preparing 1-pyriminyloxy-3-hetarylalkylamino-2-propanols and of pharmaceutical compositions containing the same | |
EG17710A (en) | Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them | |
PH23447A (en) | B-actam compounds,pharmaceutical compositions containing the same and method of use thereof | |
NZ209095A (en) | Piperidinoquinazolines and pharmaceutical compositions | |
DE3373623D1 (en) | Pharmaceutical combination composition and associated method | |
EP0143603A3 (en) | Sugar-coated pharmaceutical composition and method for preparing the same | |
GB8417154D0 (en) | Pharmaceutical composition | |
EP0180190A3 (en) | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same | |
DE3265871D1 (en) | 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same | |
NZ208244A (en) | Phenyl-pyrazol-3-ones and pharmaceutical compositions | |
IL71446A0 (en) | Composition and method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones | |
PT79113A (en) | Process for the preparation of 16-fluoro-16,17-didehydro prostanoids and of pharmaceutical compositions containing the same | |
PH19575A (en) | Cephalosporing derivatives and pharmaceutical compositions thereof | |
IL76327A (en) | Phenylacetonitrile derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
PH21779A (en) | Sulfonomidines and pharmaceutical compositions containing the same | |
GB8407735D0 (en) | Pharmaceutical composition | |
PH24745A (en) | New 1-aryloxy-3-amino-2-prppanols and pharmaceutical compositions containing the same |